DDD · CIK 910638
What 3D Systems Corporation told the SEC could break it.
3D Systems flags three distinct pressure points. It buys the raw materials and energy for assembling printers and blending print materials at market prices without commodity hedging, so a 10% move in those prices would shift its cost of sales by about $11.6 million. Its revenue also leans on a couple of large customers in its Healthcare Solutions segment — two were 12.2% and 11.4% of 2025 revenue, with one previously as high as 16.0% — so a downturn at either would weigh on results. And as an additive-manufacturing company, its products fall under U.S. export controls (ITAR, EAR and OFAC), tariffs and sanctions, where changes in classifications, licensing or end-use rules could limit sales, delay shipments and raise compliance costs.
3 self-disclosed vulnerabilities, pulled from its own filings — each in the company’s words, with the source. This is the risk register almost nobody reads.
In its own words
What could break it.
Commodity & input dependence
- Raw materials and energy for printer assembly and print-materials blendingmedium
Printer assembly and print-materials blending depend on raw materials and energy bought at market prices with no commodity hedging; a hypothetical 10% commodity price change would shift cost of sales by ~$11.6 million.
“For the year ended December 31, 2025, a hypothetical 10% change in commodity prices for raw materials would have caused a change to cost of sales of approximately $11.6 million.”
SEC filing →As of 2026
Customer concentration
- Two large Healthcare Solutions customers (12.2% and 11.4% of revenue)medium
Two customers in the Healthcare Solutions segment each accounted for over 10% of revenue (12.2% and 11.4%) in 2025, with one previously at 16.0%; losing or a downturn at these customers would materially hurt results.
“For the year ended December 31, 2025, two customers within our Healthcare Solutions segment represented 12.2% and 11.4% of our revenue, respectively. For the years ended December 31, 2024 and 2023, one of those customers also represented 16.0% and 15.0% of our revenue, respectively.”
SEC filing →As of 2026
Regulatory & policy
- U.S. export controls (ITAR/EAR/OFAC), tariffs and sanctionsmedium
Additive-manufacturing products are subject to ITAR, EAR, and OFAC controls plus tariffs and sanctions; changes in export classifications, licensing, country restrictions, or end-use rules could limit sales, delay shipments, and raise compliance costs.
“Recent and potential future changes in U.S. export control classifications, licensing requirements, country restrictions, and end-use or end-user rules may limit our ability to sell products, delay shipments, increase compliance costs or require changes to our business practices.”
The hidden graph
Who it depends on, and who depends on it.
Relationships surfaced from filings — including ones disclosed by the other side, which is how the non-obvious ones come to light.
Its customers
United Therapeutics Corporation
“The lung scaffold used in the ULung is printed using 3D printers being developed in collaboration with 3D Systems, Inc.”
Cited →
In the MyPRIA app, this is checked against the companies you actually own.
← World Watch